Covidien plc (NYSE:COV) registered for a debt offering with the Securities & Exchange Commission, aiming to drum up some cash to pay for its $2.3 billion acquisition of ev3 Inc (NSDQ:EVVV).
The Mansfield, Mass.-based medical products conglomerate filed shelf registration documents with the SEC indicating its plans to sell an unspecified amount of debt in $1,000 increments.